213 related articles for article (PubMed ID: 29559954)
1. Proteoglycans-Biomarkers and Targets in Cancer Therapy.
Nikitovic D; Berdiaki A; Spyridaki I; Krasanakis T; Tsatsakis A; Tzanakakis GN
Front Endocrinol (Lausanne); 2018; 9():69. PubMed ID: 29559954
[TBL] [Abstract][Full Text] [Related]
2. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
Theocharis AD; Skandalis SS; Tzanakakis GN; Karamanos NK
FEBS J; 2010 Oct; 277(19):3904-23. PubMed ID: 20840587
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors.
Tzanakakis G; Giatagana EM; Kuskov A; Berdiaki A; Tsatsakis AM; Neagu M; Nikitovic D
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847060
[TBL] [Abstract][Full Text] [Related]
4. Proteoglycans and Immunobiology of Cancer-Therapeutic Implications.
Tzanakakis G; Neagu M; Tsatsakis A; Nikitovic D
Front Immunol; 2019; 10():875. PubMed ID: 31068944
[TBL] [Abstract][Full Text] [Related]
5. Proteoglycans as Therapeutic Targets in Brain Cancer.
Yan Z; Wang S
Front Oncol; 2020; 10():1358. PubMed ID: 32850434
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycans: key partners in bone cell biology.
Lamoureux F; Baud'huin M; Duplomb L; Heymann D; Rédini F
Bioessays; 2007 Aug; 29(8):758-71. PubMed ID: 17621645
[TBL] [Abstract][Full Text] [Related]
7. Involvement of stromal proteoglycans in tumour progression.
Wegrowski Y; Maquart FX
Crit Rev Oncol Hematol; 2004 Mar; 49(3):259-68. PubMed ID: 15036265
[TBL] [Abstract][Full Text] [Related]
8. Antithetic roles of proteoglycans in cancer.
Garusi E; Rossi S; Perris R
Cell Mol Life Sci; 2012 Feb; 69(4):553-79. PubMed ID: 21964924
[TBL] [Abstract][Full Text] [Related]
9. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
10. The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer.
Skandalis SS; Kletsas D; Kyriakopoulou D; Stavropoulos M; Theocharis DA
Biochim Biophys Acta; 2006 Aug; 1760(8):1217-25. PubMed ID: 16730906
[TBL] [Abstract][Full Text] [Related]
11. Proteoglycans in stem cells.
Gasimli L; Linhardt RJ; Dordick JS
Biotechnol Appl Biochem; 2012; 59(2):65-76. PubMed ID: 23586787
[TBL] [Abstract][Full Text] [Related]
12. Modulation of collagen fibrillogenesis by dentinal proteoglycans.
Milan AM; Sugars RV; Embery G; Waddington RJ
Calcif Tissue Int; 2005 Feb; 76(2):127-35. PubMed ID: 15549638
[TBL] [Abstract][Full Text] [Related]
13. Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and Cancer.
Couchman JR; Multhaupt H; Sanderson RD
F1000Res; 2016; 5():. PubMed ID: 27408707
[TBL] [Abstract][Full Text] [Related]
14. The identification of proteoglycans and glycosaminoglycans in archaeological human bones and teeth.
Coulson-Thomas YM; Coulson-Thomas VJ; Norton AL; Gesteira TF; Cavalheiro RP; Meneghetti MC; Martins JR; Dixon RA; Nader HB
PLoS One; 2015; 10(6):e0131105. PubMed ID: 26107959
[TBL] [Abstract][Full Text] [Related]
15. Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.
Farnedi A; Rossi S; Bertani N; Gulli M; Silini EM; Mucignat MT; Poli T; Sesenna E; Lanfranco D; Montebugnoli L; Leonardi E; Marchetti C; Cocchi R; Ambrosini-Spaltro A; Foschini MP; Perris R
BMC Cancer; 2015 May; 15():352. PubMed ID: 25935541
[TBL] [Abstract][Full Text] [Related]
16. Signaling at the Crossroads: Matrix-Derived Proteoglycan and Reactive Oxygen Species Signaling.
Nastase MV; Janicova A; Wygrecka M; Schaefer L
Antioxid Redox Signal; 2017 Oct; 27(12):855-873. PubMed ID: 28510506
[TBL] [Abstract][Full Text] [Related]
17. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
18. Utility and control of proteoglycans in tissue engineering.
Ferdous Z; Grande-Allen KJ
Tissue Eng; 2007 Aug; 13(8):1893-904. PubMed ID: 17518731
[TBL] [Abstract][Full Text] [Related]
19. The contribution of proteoglycans to the mechanical behavior of mineralized tissues.
Bertassoni LE; Swain MV
J Mech Behav Biomed Mater; 2014 Oct; 38():91-104. PubMed ID: 25043659
[TBL] [Abstract][Full Text] [Related]
20. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.
Tímár J; Lapis K; Dudás J; Sebestyén A; Kopper L; Kovalszky I
Semin Cancer Biol; 2002 Jun; 12(3):173-86. PubMed ID: 12083848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
